
MANILA, Philippines — Pharmaceutical giant AstraZeneca is expanding its clinical trial footprint in the Philippines by tapping the Ayala Group’s health-care arm to identify and prepare additional hospitals where it can conduct research and…
View original source — Philippine Daily Inquirer ↗



